Jenburkt Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹43.07Cr
Net Profits
₹9.60Cr
Net Profit Margins
22.29%
Highlights
Revenue:

Jenburkt Pharmaceuticals Ltd’s revenue jumped 9.37% since last year same period to ₹43.07Cr in the Q2 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 26.9% jump in its revenue since last 3-months.

Net Profits:

Jenburkt Pharmaceuticals Ltd’s net profit jumped 31.15% since last year same period to ₹9.60Cr in the Q2 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 29.38% jump in its net profits since last 3-months.

Net Profit Margins:

Jenburkt Pharmaceuticals Ltd’s net profit margin jumped 19.91% since last year same period to 22.29% in the Q2 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 1.95% jump in its net profit margins since last 3-months.

FAQs

The revenue for Jenburkt Pharmaceuticals Ltd in the Q2 results 2024 was ₹43.07Cr.

The net profit for Jenburkt Pharmaceuticals Ltd in the Q2 results 2024 was ₹9.60Cr.

The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q2 results 2024 was 22.29%.

The revenue for Jenburkt Pharmaceuticals Ltd in the Q2 results 2023 was ₹39.38Cr.

The net profit for Jenburkt Pharmaceuticals Ltd in the Q2 results 2023 was ₹7.32Cr.

The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q2 results 2023 was 18.59%.